SCHEMBL2446840

SCHEMBL2446840

C=C=CC(=O)N(C(=O)C=C)C(=O)C=C

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL181176 0.81 LMNA (0.44) LMNA
SCHEMBL3622188 0.78 LMNA (0.41) LMNA
SCHEMBL3202774 0.69
SCHEMBL8743203 0.67 LMNA (0.44) LMNA
SCHEMBL6379416 0.65 ALDH1A1 (0.47) LMNA
Acrylic Acid SCHEMBL1809604 0.65 LMNA (0.59) LMNA
SCHEMBL372525 0.65 ALDH1A1 (0.47) LMNA
SCHEMBL9567032 0.65 ALDH1A1 (0.47) LMNA
Acrylic Acid SCHEMBL11288299 0.63 LMNA (0.56) LMNA
Acrylamide SCHEMBL28699720 0.63 ALDH1A1 (0.61) LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2547688-B1 SILICONE (METH)ACRYLAMIDE MONOMER, POLYMER, OPHTHALMIC LENS, AND CONTACT LENS JOHNSON & JOHNSON VISION CARE (US) 2014-12-17 EP disclosed
US-8623934-B2 Silicone (meth)acrylamide monomer, polymer, ophthalmic lens, and contact lens JOHNSON & JOHNSON VISION CARE, INC. (US) 2014-01-07 US disclosed
US-8541483-B2 Silicone (meth)acrylamide monomer, polymer, ophthalmic lens, and contact lens JOHNSON & JOHNSON VISION CARE, INC. (US) 2013-09-24 US disclosed
US-20130197176-A1 SILICONE (METH)ACRYLAMIDE MONOMER, POLYMER, OPHTHALMIC LENS, AND CONTACT LENS JOHNSON & JOHNSON VISION CARE, INC. (US) 2013-08-01 US disclosed
US-20130178594-A1 SILICONE (METH)ACRYLAMIDE MONOMER, POLYMER, OPHTHALMIC LENS, AND CONTACT LENS JOHNSON & JOHNSON VISION CARE, INC. (US) 2013-07-11 US disclosed
US-8415405-B2 Silicone (meth)acrylamide monomer, polymer, ophthalmic lens, and contact lens JOHNSON & JOHNSON VISION CARE, INC. (US) 2013-04-09 US disclosed
EP-2547688-A1 SILICONE (METH)ACRYLAMIDE MONOMER, POLYMER, OPHTHALMIC LENS, AND CONTACT LENS Johnson & Johnson Vision Care, Inc. (US) 2013-01-23 EP disclosed
US-20110237766-A1 SILICONE (METH)ACRYLAMIDE MONOMER, POLYMER, OPHTHALMIC LENS, AND CONTACT LENS JOHNSON & JOHNSON VISION CARE, INC. 2011-09-29 US disclosed
WO-2011116206-A1 SILICONE (METH)ACRYLAMIDE MONOMER, POLYMER, OPHTHALMIC LENS, AND CONTACT LENS JOHNSON & JOHNSON VISION CARE, INC. (US) 2011-09-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130197176-A1 SILICONE (METH)ACRYLAMIDE MONOMER, POLYMER, OPHTHALMIC LENS, AND CONTACT LENS CRYAA, MGMT, UACA LMNA 2848/4885
US-20110237766-A1 SILICONE (METH)ACRYLAMIDE MONOMER, POLYMER, OPHTHALMIC LENS, AND CONTACT LENS CRYAA, MGMT, UACA LMNA 2848/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.